ASPYRE THERAPY SOLUTIONS LTD

(formerly RMSM INNOVATIONS LIMITED)

Registered Number
11400777
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

Company Information
for the year from 1 April 2024 to 31 March 2025


Directors	MANZO, Maria
	MANZO, Rino


Company Secretary	MANZO, Rino


Registered Number	11400777 (England and Wales)

ASPYRE THERAPY SOLUTIONS LTD

Balance Sheet as at
31 March 2025

	2025 £	2024 £

Fixed Assets	168,324	168,529

Current Assets	1,395	2,016
Creditors amounts falling due within one year	(1,373)	(118,345)
Net current assets (liabilities)	22	(116,329)

Total assets less current liabilities	168,346	52,200

Creditors amounts falling due after one year	(118,300)	-
Accruals and deferred income	(534)	(2,389)
Net assets (liabilities)	49,512	49,811
Capital and reserves	49,512	49,811

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 0 (previous period: 0).

The financial statements were approved and authorised for issue by the Board of Directors on 12 December 2025, and are signed on its behalf by:

MANZO, Maria
Director

MANZO, Rino
Director

Registered Company No. 11400777